Literature DB >> 1849769

An amplifying effect of exogenous and neurally stored 5-hydroxytryptamine on the neurogenic contraction in rat tail artery.

C Szabó1, J E Hardebo, C Owman.   

Abstract

1. The interactions between sympathetic neuroeffector transmission and 5-hydroxytryptamine (5-HT) were investigated in segments of rat isolated tail artery. 2. Contractile responses to field stimulation of the artery segments were abolished by tetrodotoxin (3 x 10(-7) M). A subthreshold concentration of acutely applied exogenous 5-HT (10(-8) M) markedly enhanced the contractions induced by sympathetic nerve stimulation, through an action on postjunctional 5-HT2-receptors. 3. The amplifying effect of 5-HT involved an enhanced influx of extracellular calcium into the smooth muscle cells. In contrast, the neurogenic contractions in vessels not exposed to 5-HT were not dependent on extracellular calcium. 4. The adrenergic component of the amplified response involved postjunctional alpha 1- but not alpha 2- adrenoceptor activation. 5. Exposure of the vessels to 5-HT (5 x 10(-7) M) for 30 min resulted in uptake of the amine into the perivascular sympathetic nerves, as demonstrated by immunohistochemistry. After chemical sympathectomy with 6-hydroxydopamine in vitro or in vivo, or surgical sympathectomy, there was little or no uptake. 6. Exposure to 5-HT followed by repeated washing resulted in an enhancement of the neurogenic contraction, which was still fully tetrodotoxin-sensitive. The enhanced response was blocked by ketanserin (10(-8) M) and prevented by the presence of the 5-HT uptake blocker, paroxetine (3 x 10(-8) M), during the period of exposure to 5-HT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849769      PMCID: PMC1918028          DOI: 10.1111/j.1476-5381.1991.tb12186.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  Evidence against serotonin as a vasoconstrictor neurotransmitter in the rabbit basilar artery.

Authors:  B Levitt; S P Duckles
Journal:  J Pharmacol Exp Ther       Date:  1986-09       Impact factor: 4.030

2.  Amplification by serotonin of responses to other vasoconstrictor agents in the rat tail artery.

Authors:  X H Xiao; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1989-09       Impact factor: 2.557

3.  The effects of Bay K 8644 and nifedipine on the neural responses of the rabbit ear artery.

Authors:  D W Cheung; M J MacKay
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

Review 4.  Sympathetic neuroeffector transmission in arteries and arterioles.

Authors:  G D Hirst; F R Edwards
Journal:  Physiol Rev       Date:  1989-04       Impact factor: 37.312

Review 5.  Alpha-adrenoceptor stimulation and calcium movements.

Authors:  P A van Zwieten; P B Timmermans
Journal:  Blood Vessels       Date:  1987

6.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

7.  Effects of reduced calcium ion concentration and of diltiazem on vasoconstrictor responses to noradrenaline and sympathetic nerve stimulation in rat isolated tail artery.

Authors:  I C Medgett; M A Rajanayagam
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

8.  Serotonin potentiates noradrenaline-induced vasoconstriction through 5-HT1-type receptors in guinea pig basilar artery.

Authors:  J Y Chang; C Owman
Journal:  J Cereb Blood Flow Metab       Date:  1989-10       Impact factor: 6.200

Review 9.  Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.

Authors:  J M Van Nueten; W J Janssens; R Xhonneux; P A Janssen
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

10.  Studies on the site of the interaction between alpha 1-adrenoceptors and 5-HT2 receptors in rat tail arteries.

Authors:  J F Marwood
Journal:  J Cardiovasc Pharmacol       Date:  1988       Impact factor: 3.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.